1,484
Participants
Start Date
November 7, 2022
Primary Completion Date
October 30, 2023
Study Completion Date
January 30, 2025
V116
Sterile 0.5 mL solution in prefilled syringe containing 4 μg of each pneumococcal polysaccharide (PnPs) antigen 3, 6A, 7F, 8, 9N, 10A, 11A, 12F, 15A, 15C, 16F, 17F, 19A, 20A, 22F, 23A, 23B, 24F, 31, 33F, and 35B.
PPSV23
Sterile 0.5 mL solution in prefilled syringe containing 25 μg of each PnPs antigen 1, 2, 3, 4, 5, 6B, 7F, 8, 9N, 9V, 10A, 11A, 12F, 14, 15B, 17F, 18C, 19A, 19F, 20, 22F, 23F, and 33F.
National Taiwan University Hospital ( Site 1900), Taipei
Chang Gung Medical Foundation-Linkou Branch ( Site 1902), Taoyuan District
National Cheng Kung University Hospital ( Site 1901), Tainan City
Kaohsiung Medical University Chung-Ho Memorial Hospital-Infectious diseases Division, Department of, Kaohsiung City
Optimal Clinical Trials ( Site 1600), Auckland
Northern Beaches Clinical Research ( Site 1502), Brookvale
Paratus Clinical Research Western Sydney ( Site 1500), Blacktown
Paratus Clinical Research Brisbane ( Site 1501), Albion
P3 Research - Palmerston North ( Site 1602), Palmerston North
P3 Research - Lower Hutt ( Site 1601), Lower Hutt
Soon Chun Hyang University Bucheon Hospital ( Site 1812), Bucheon-si
Korea University Ansan Hospital ( Site 1801), Ansan-si
The Catholic University Of Korea St. Vincent's Hospital-Internal Medicine ( Site 1803), Suwon
Hallym University Dongtan Sacred Heart Hospital ( Site 1813), Hwaseong-si
Universitaetsklinikum Hamburg-Eppendorf-Infektiologie ( Site 0901), Hamburg
Wonju Severance Christian Hospital ( Site 1808), Wŏnju
Hospital La Princesa-Clinical Pharmacology ( Site 1115), Madrid
Hospital Universitario Getafe ( Site 1111), Getafe
Acibadem Universitesi Atakent Hastanesi-Infectious Disease ( Site 1301), Istanbul
Sancaktepe Şehit Prof.Dr. İlhan Varank Eğitim ve Arastirma Hastanesi ( Site 1305), Sancaktepe
Chungnam national university hospital ( Site 1814), Junggu
Kyungpook National University Chilgok Hospital-Division of Infectious Diseases ( Site 1804), Deagu
Medizentrum Essen Borbeck ( Site 0902), Essen
Fundación Oftalmologica del Mediterraneo-Vaccine Research ( Site 1118), Valencia
Dong-A University Hospital ( Site 1810), Busan
Universitaetsklinikum Koeln ( Site 0900), Cologne
InfektioResearch ( Site 0903), Frankfurt am Main
Chonnam National University Hospital-Infectious Diseases ( Site 1811), Gwangju
IPS Centro Científico Asistencial S.A.S ( Site 0407), Barranquilla
klinikum rechts der isar der technischen universität münchen ( Site 0904), München
Fundacion Valle del Lili- CIC ( Site 0415), Santiago de Cali
Clalit Health Services - Sakhnin Community Clinic-Research Unit ( Site 1001), Sakhnin
Rambam Health Care Campus ( Site 1002), Haifa
Meir Medical Center-Infectious unit ( Site 1003), Kfar Saba
Sheba Medical Center ( Site 1000), Ramat Gan
Hadassah Medical Center-Clinical Reaserch Unit ( Site 1004), Jerusalem
Fundacion Estudios Clinicos ( Site 0200), Rosario
The Catholic University of Korea, Eunpyeong St. Mary's Hospital ( Site 1802), Seoul
Asan Medical Center ( Site 1809), Seoul
The Catholic Univ. of Korea Seoul St. Mary's Hospital ( Site 1806), Seoul
Hallym University Kangnam Sacred Heart Hospital ( Site 1807), Seoul
Ewha Womans University Mokdong Hospital-Infectious Diseases ( Site 1805), Seoul
Korea University Guro Hospital ( Site 1800), Seoul
EBA CENTELLES ( Site 1100), Centelles
Centre d'Atenció Primària Vallcarca - Sant Gervasi ( Site 1101), Barcelona
EAP Sardenya ( Site 1102), Barcelona
ANKARA UNIVERSITY IBNI SINA HOSPITAL ( Site 1304), Ankara
Hacettepe Universite Hastaneleri-İnfection ( Site 1300), Ankara
Gazi University Health Research and Application Center Gazi Hospital-Enfeksiyon Hastalıkları ( Site, Ankara
Accellacare - Yorkshire-MeDiNova Yorkshire ( Site 1405), Shipley
Barts Health NHS Trust-William Harvey Clinical Research Centre ( Site 1407), London
Royal Free Hospital-Ian Charleson Day Centre RESEARCH ( Site 1402), London
Layton Medical Centre ( Site 1400), Blackpool
Accellacare - Northamptonshire ( Site 1403), Corby
Accellacare - Warwickshire ( Site 1404), Coventry
Merck Sharp & Dohme LLC
INDUSTRY